GM1 ganglioside as a potential treatment in tardive dyskinesia
Peselow, E.D.; Irons, S.; Rotrosen, J.; Alonso, M.T.; Dorsey, F.
Psychopharmacology Bulletin 25(2): 277-280
1989
ISSN/ISBN: 0048-5764 PMID: 2602520 Document Number: 327889
Document emailed within 1 workday
Related Documents
Huh, L.; Lee, B.Ju. 2015: Efficacy of aripiprazole in antidepressants-induced tardive dystonia and tardive dyskinesia: a case report Psychiatria Danubina 27(2): 195-197Branchey, M.H.; Branchey, L.B.; Bark, N.M.; Richardson, M.A. 1979: Lecithin in the treatment of tardive dyskinesia Communications in Psychopharmacology 3(5): 303-307
Camp, E.W. 1977: Tardive dyskinesia oral facial dyskinesia with moban Diseases of the Nervous System 38(9): 759
Wolf, M.A.; Gautier, J. 1987: Physiopathology and curative treatment of tardive dyskinesia L'Encephale 13(5): 301-308
Jus, A.; Jus, K.; Fontaine, P. 1979: Long term treatment of tardive dyskinesia Journal of Clinical Psychiatry 40(2): 72-77
Rust, M. 1983: Use of tiapride in persistent tardive dyskinesia following treatment with neuroleptics Münchener Medizinische Wochenschrift 125(21): 461-462
Marsálek, M. 1989: Tardive dyskinesia after low doses of neuroleptics and attempts at treatment Ceskoslovenska Psychiatrie 85(2): 100-105
Bajulaiye, R.; Addonizio 1992: Clozapine in the treatment of psychosis in an 82-year-old woman with tardive dyskinesia Journal of Clinical Psychopharmacology 12(5): 364-365
Sajjad, S.H. 1998: Vitamin E in the treatment of tardive dyskinesia: a preliminary study over 7 months at different doses International Clinical Psychopharmacology 13(4): 147-155
Gualtieri, C.T.; Sprague, R.L. 1984: Preventing tardive dyskinesia and preventing tardive dyskinesia litigation Psychopharmacology Bulletin 20(3): 346-348
Christensen, A.V.; Nielsen, I.M. 1980: Dopaminergic supersensitivity: influence of dopamine agonists and drugs used for the treatment of tardive dyskinesia Advances in Biochemical Psychopharmacology 24: 341-349
Fahn, S. 1983: Long-term treatment of tardive dyskinesia with presynaptically acting dopamine-depleting agents Advances in Neurology 37: 267-276
Spivak, B.; Mester, R.; Abesgaus, J.; Wittenberg, N.; Adlersberg, S.; Gonen, N.; Weizman, A. 1997: Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients Journal of Clinical Psychiatry 58(7): 318-322
Fuller, R.W.; Clemens, J.A.; Hynes, M.D. 1982: Degree of selectivity of pergolide as an agonist at presynaptic versus postsynaptic dopamine receptors: implications for prevention or treatment of tardive dyskinesia Journal of Clinical Psychopharmacology 2(6): 371-375
Mehta, D.; Eaton, J.; Burch, M.; Mehta, S. 1985: Observations in tardive dyskinesia Journal of Clinical Psychiatry 46(2): 73
Gunne, L.M.; Häggström, J.E. 1985: Experimental tardive dyskinesia Journal of Clinical Psychiatry 46(4 Pt 2): 48-50
Chowdhury, K.L.; Jalali, R.K.; Abrol, A.; Saproo, R.K.; Shah, B.A.; Tramboo, R. 1991: Polypharmacy and tardive dyskinesia Journal of the Association of Physicians of India 39(6): 501-503
Granacher, R.P. 1978: The tardive dyskinesia syndrome Journal of the Kentucky Medical Association 76(1): 13-17
Wolf, M.E.; DeWolfe, A.S.; Ryan, J.J.; Lips, O.; Mosnaim, A.D. 1985: Vulnerability to tardive dyskinesia Journal of Clinical Psychiatry 46(9): 367-368
Gunne, L.M.; Häggström, J.E.; Johansson, P.; Levin, E.D.; Terenius, L. 1988: Neurobiochemical changes in tardive dyskinesia L'Encephale 14(Special Issue): 167-173